Treatment Regimen and Outcomes in Acute Retinal Necrosis: An IRIS® Registry Study.

Authors

• Ines Lains
• Alexander Ivanov
• Connor Ross
• Nathan Hall
• Tobias Elze
• Alice Lorch
• Joan W Miller
• Lucia Sobrin
• Dan Gong

Publication/Presentation Date

12-1-2024

Abstract

IRIS (Intelligent Research in Sight) Registry Study showing that acute retinal necrosis cases treated with systemic antivirals alone vs combined with intravitreal antivirals or early vitrectomy had statistically similar outcomes at 6 and 12 months.

Volume

131

Issue

12

First Page

1468

Last Page

1470

ISSN

1549-4713

Published In/Presented At

Lains, I., Ivanov, A., Ross, C., Hall, N., Elze, T., Lorch, A., Miller, J. W., Sobrin, L., Gong, D., & IRIS® Registry Data Analytic Center Consortium (2024). Treatment Regimen and Outcomes in Acute Retinal Necrosis: An IRIS® Registry Study. Ophthalmology, 131(12), 1468–1470. https://doi.org/10.1016/j.ophtha.2024.07.020

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

39033858

Department(s)

Administration and Leadership

Document Type

Article